We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Approves New Indication for OIC Drug Relistor
Salix Pharmaceuticals and Progenics Pharmaceuticals said they had received FDA clearance for a new indication on their opioid-induced constipation drug Relistor.